文献速递浆细胞疾病淋巴瘤

AL淀粉样变中浆细胞病的细胞遗传学克隆内异质性:与多发性骨髓瘤的比较

Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myeloma.
PubMed 文献 · Blood Adv · 2018-01-01

该研究比较了544例系统性轻链淀粉样变(PC-AL)患者与519例PC-non-AL患者(MGUS、SMM或症状性MM)的浆细胞病克隆与亚克隆组成。PC-AL组亚克隆检出率36.6%(199/544)低于PC-non-AL组的51.4%(267/519),P<.001,且亚克隆与浆细胞病分期无关。t(11;14)与较低亚克隆形成率相关,超二倍体与较高亚克隆形成率相关;PC-AL本身失去统计学显著性,提示AL中亚克隆频率较低反映其t(11;14)频率极高。

要点

  • PC-AL组亚克隆检出率36.6%(199/544),低于PC-non-AL组的51.4%(267/519),P<.001。
  • 两组中亚克隆与浆细胞病分期(MGUS、SMM、MM)无关,亚克隆/主克隆比值无分期相关变化。
  • t(11;14)通常为主克隆,与较低亚克隆形成率相关;超二倍体与较高亚克隆形成率相关。

核心结论

  • PC-AL与PC-non-AL的亚克隆模式密切相关,提示亚克隆形成取决于主要细胞遗传学类别,而与疾病实体和分期无关。
  • PC-AL本身在多变量分析中失去统计学显著性,表明AL中亚克隆频率较低反映其t(11;14)频率极高。

研究设计与样本

  • 比较544例系统性轻链淀粉样变(PC-AL)患者与519例PC-non-AL患者(MGUS、SMM或症状性MM)的浆细胞病克隆与亚克隆组成。
  • 采用间期荧光原位杂交,亚克隆严格定义为克隆大小低于最大克隆的三分之二且绝对差异≥30%。

主要发现

  • 亚克隆在PC-AL组检出199例(36.6%,199/544),在PC-non-AL组检出267例(51.4%,267/519),P<.001。
  • 两组中亚克隆与浆细胞病分期均无关;亚克隆/主克隆比值不随MGUS、SMM或MM分期变化。
  • 两组中t(11;14)、其他免疫球蛋白重链易位及超二倍体通常为主克隆,而1q21增益及8p21、13q14、17p13缺失常见为亚克隆。
  • 多变量分析中,t(11;14)与较低亚克隆形成率相关,超二倍体与较高亚克隆形成率相关;PC-AL本身失去统计学显著性。

关键数值与推荐

  • 亚克隆定义:克隆大小低于最大克隆的三分之二且绝对差异≥30%。
  • PC-AL组亚克隆199/544(36.6%)vs PC-non-AL组267/519(51.4%),P<.001。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Analysis of intraclonal heterogeneity has yielded insights into the clonal evolution of hematologic malignancies. We compared the clonal and subclonal compositions of the underlying plasma cell dyscrasia in 544 systemic light chain amyloidosis (PC-AL) patients with 519 patients with monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), or symptomatic MM; ie, PC-non-AL patients). Using interphase fluorescence in situ hybridization, subclones were stringently defined as clone size below two thirds of the largest clone and an absolute difference of ≥30%. Subclones were found less frequently in the PC-AL group, at 199 (36.6%) of 544 as compared with 267 (51.4%) of 519 in the PC-non-AL group (P < .001), and were not associated with the stage of plasma cell dyscrasia in either entity. In both groups, translocation t(11;14), other immunoglobulin heavy chain translocations, and hyperdiploidy were typically found as main clones, whereas gain of 1q21 and deletions of 8p21, 13q14, and 17p13 were frequently found as subclones. There were no shifts in the subclone/main clone ratio depending on the MGUS, SMM, or MM stage of plasma cell dyscrasia. In multivariate analysis, t(11;14) was associated with lower rates of subclone formation and hyperdiploidy with higher rates. PC-AL itself lost statistical significance, demonstrating that the lower subclone frequency in AL is a reflection of its exceptionally high t(11;14) frequency. In summary, the subclone patterns in PC-AL and PC-non-AL are closely related, implying that subclone formation depends on the main cytogenetic categories and is independent of disease entity and stage.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Bochtler T, Merz M, Hielscher T, et al. Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myeloma. Blood Adv. 2018. PMID: 30327369. doi:10.1182/bloodadvances.2018023200

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。